LATEST NEWS
Science, Tech & Medicine
FDA Greenlights Revolutionary Sickle Cell Therapies from Vertex and CRISPR, Cracking $2 Million Cost Conundrum
The FDA approves a new gene therapy, Casgevy, for sickle cell disease in patients aged 12 and older, along with a second treatment, Lyfgenia, offering new options for this life-threatening disorder.
UMass Amherst Researchers Forge Grassroots Framework for Environmental Stewardship in Honduras
UMass Amherst researchers developed a grassroots ecological framework focusing on local engagement for environmental management, as detailed in PLOS ONE, and applied it to the Lake Yojoa watershed in Honduras.